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Abstract
HIV serostatus disclosure among people living with HIV/AIDS (PLWHA) is an important
component of preventing HIV transmission to sexual partners. Due to barriers like stigma,
however, many PLWHA do not disclose their serostatus to all sexual partners. This study explored
differences in HIV serostatus disclosure based on sexual behavior subgroup [men who have sex
with men (MSM), heterosexual men, and women], characteristics of the sexual relationship
(relationship type and HIV serostatus of partner), and perceived stigma. We examined disclosure
in a sample of 341 PLWHA: 138 MSM, 87 heterosexual men, and 116 heterosexual women who
were enrolled in SafeTalk, a randomized, controlled trial of a safer sex intervention. We found
that, overall, 79% of participants disclosed their HIV status to all sexual partners in the past 3
months. However, we found important differences in disclosure by subgroup and relationship
characteristics. Heterosexual men and women were more likely to disclose their HIV status than
MSM (86%, 85%, and 69%, respectively). Additionally, disclosure was more likely among
participants with only primary partners than those with only casual or both casual and primary
partners (92%, 54%, and 62%, respectively). Participants with only HIV-positive partners were
also more likely to disclose than those with only HIV-negative partners, unknown serostatus
partners, or partners of mixed serostatus (96%, 85%, 40%, and 60%, respectively). Finally, people
who perceived more HIV-related stigma were less likely to disclose their HIV serostatus to
partners, regardless of subgroup or relationship characteristics. These findings suggest that
interventions to help PLWHA disclose, particularly to serodiscordant casual partners, are needed
and will likely benefit from inclusion of stigma reduction components.
Manuscript Correspondence: Sarahmona M. Przybyla, PhD, MPH Research Assistant Professor Center for Pharmaceutical
Marketing and Management University of Mississippi Faser 128 University, MS 38677 Phone: 662-915-1942 przybyla@olemiss.edu.
NIH Public Access
Author Manuscript
AIDS Care. Author manuscript; available in PMC 2014 May 01.
Published in final edited form as:














HIV serostatus disclosure; stigma; gender differences; sexual partners
HIV serostatus disclosure is an important component of preventing HIV transmission from
people living with HIV/AIDS (PLWHA) to their sexual partners, allowing partners to make
informed choices before sexual contact. Not only has disclosure been linked to increased
condom use and decreased disease transmission (Crepaz & Marks, 2003; Parsons et al.,
2005), disclosure also allows serodiscordant couples to take measures to prevent HIV
transmission, including the use of pre-exposure prophylaxis and antiretroviral treatment
adherence (Brooks et al., 2011; Cohen et al., 2011).
While a substantial body of research has informed our understanding of factors influencing
disclosure, at least three gaps remain. First, most research has assessed disclosure within
specific subgroups, such as men who have sex with men (MSM) (Klitzman et al., 2007;
Marks & Crepaz, 2001; O’Brien et al., 2003), bisexual men (Mutchler et al., 2008), or
women (Sowell et al., 2003; Sullivan, Voss, & Li, 2010), but has not directly compared
disclosure patterns among subgroups of PLWHA. Second, the extent to which partner-
specific variables, such as partner serostatus and relationship type, influence HIV disclosure
among different subgroups is unknown. Finally, although previous studies have
demonstrated an inverse relationship between HIV stigma and disclosure (Smith, Rossetto,
& Peterson, 2008), little research exists regarding the stigma-disclosure association by
subgroups. Understanding group differences in disclosure could allow for more targeted
prevention programs.
The current study assessed disclosure to sexual partners in a clinically representative,
sexually active population of PLWHA. In the full sample and across subgroups of MSM,
heterosexual men, and women, our aims were to describe and compare: 1) sexual partner
characteristics (relationship type and partner serostatus); 2) the prevalence of disclosure
based on partner characteristics; 3) the prevalence of HIV stigma and its association with
disclosure; and 4) whether subgroup and sexual partnership characteristics moderated the
relationship between HIV stigma and disclosure.
Methods
Participants and Procedures
Data come from the baseline survey of SafeTalk, a randomized, controlled trial of a safer-
sex intervention of 490 PLWHA (see Golin et al., 2012 and Widman, Golin, Grodensky, &
Suchindran, 2012 for detailed study information). The University of North Carolina at
Chapel Hill’s Office for the Protection of Human Research approved all study procedures.
Measures
Subgroups—We determined sexual behavior subgroup (i.e., MSM, heterosexual men, or
women) based on participant gender and the gender of their reported sexual partners.
Relationship Type and Partner Serostatus—Based on questions about sexual
partners in the last three months, we created a three-category variable for relationship type:
1) only primary partner(s); 2) only casual partner(s); or 3) a combination of primary and
casual partner(s). We determined the proportion of partners by serostatus to create a four-
category variable: 1) only HIV-positive partner(s); 2) only HIV-negative partner(s); 3) only
unknown serostatus partner(s); or 4) a combination of HIV-positive, HIV-negative, and/or
unknown serostatus partners.
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HIV Stigma—We measured HIV stigma with an abbreviated seven-item disclosure
concerns subscale of the HIV Stigma Scale (Berger, Ferrans, & Lashley, 2001; Cronbach’s
α = .87).
HIV Serostatus Disclosure—Participants indicated their number of sexual partners and
the number of their partners who “knew that you were HIV-positive because you told them
that you were positive”. From this, we derived a dichotomous HIV serostatus disclosure
variable: 1) “disclosure” (i.e., disclosure to all partners) and 2) “non-disclosure” (i.e.,
disclosure to less than 100% of partners).
Statistical Analyses
First, we conducted Chi Square analyses with Bonferroni-adjusted post-hoc tests to
determine if partnership characteristics differed by subgroup. Next, we examined the
percentage of participants who disclosed and used individual logistic regression models to
determine if the odds of disclosure varied by subgroup. We used logistic regression to
determine if the odds of disclosure varied by relationship type or partner serostatus. Follow-
up Chi Square analyses with Bonferroni-adjusted post-hoc tests were used to determine if
disclosure differed between subgroups by partnership characteristics. Further, we examined
mean differences in HIV stigma within subgroups using a one-way ANOVA, and examined
the main effect of stigma on disclosure using logistic regression. Finally, we examined
interactions between stigma, subgroups, and sexual partnership characteristics to determine
if subgroups moderated the relationship between stigma and disclosure.
Results
Participant and Partnership Characteristics (Tables 1 and 2)
We excluded 149 participants from the original 490 in SafeTalk for this analysis: 105 who
were sexually abstinent; 32 who had missing data on disclosure; 8 women who reported
sexual activity exclusively with women; and 4 transgendered individuals. The final sample
included 341 individuals: 138 MSM (40%), 87 heterosexual men (26%), and 116
heterosexual women (34%). See Table 1 for descriptive data and Table 2 for sexual
partnership characteristics. Notably, 42% of participants had HIV-negative sexual partners
and 17% had partners of unknown serostatus.
Prevalence of HIV Serostatus Disclosure (Figure 1)
Across the full sample, 79% of individuals disclosed their HIV status to all sexual partners
in the previous three months. Disclosure was more likely among women (85%) and
heterosexual men (86%) than MSM (69%) (OR = 2.63, 95% CI [1.40, 4.94], p < .01 and OR
= 2.82, 95% CI [1.39, 5.74], p < .01, respectively).
Differences in Disclosure Based on Partnership Characteristics
Relationship Type (Figure 2)—Disclosure was less likely among participants with only
casual partners (54%) and mixed relationship types (62%) relative to those with only
primary partners (92%) (OR = 0.10, 95% CI [0.05, 0.19], p < .001 and OR = 0.14, 95% CI
[0.06, 0.31], p < .001, respectively). The proportion of participants who disclosed did not
differ significantly among subgroups (Table 3).
Partner Serostatus (Figure 3)—Relative to disclosure to HIV-positive partners
(96.3%), disclosure was less likely to HIV-negative partners (84.6%), unknown serostatus
partners (40.3%), and mixed serostatus partners (60.0%) (OR = 0.23, 95% CI [0.08, 0.70], p
= .01; OR = 0.03, 95% CI [0.01, 0.09], p < .001; and OR = 0.07, 95% CI [0.02, 0.25], p < .
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001, respectively). The association between disclosure and partner serostatus varied by
subgroup when partner serostatus was unknown [χ2 (2) = 9.29, p < .01] (Table 3).
Specifically, MSM had less disclosure to unknown serostatus partners (22.6%) than did
women (69%), χ2 (1) = 9.04, p < .01.
HIV Stigma and Disclosure
HIV stigma (full sample M = 21.57, SD = 5.67) did not differ between subgroups: MSM (M
= 22.14, SD = 5.47), heterosexual men (M = 20.65, SD = 5.76) and women (M = 21.58, SD
= 5.79), F(2, 330) = 1.82, p = .16. Importantly, HIV stigma was inversely associated with
disclosure, where greater stigma was associated with lower odds of being in the disclosure
group (OR = 0.89, 95% CI [0.81, 0.93], p < .001). The relationship between stigma and
disclosure was not moderated by subgroup or sexual partner characteristics.
Discussion
This study analyzed HIV disclosure among sexually active PLWHA that included three
subgroups – MSM, heterosexual men, and women – and explored whether disclosure
differed among these groups by sexual partner serostatus or relationship status. Overall, 21%
of participants failed to disclose to all sexual partners, with MSM being least likely to
disclose (Weinhardt et al., 2004). Participants with casual or mixed relationships disclosed
less than those in exclusively primary relationships (Duru et al., 2006, Vu et al., 2012) and
less to HIV-negative, unknown, and mixed serostatus partners than to HIV-positive partners
(Klitzman et al., 2007; McKay & Mutchler, 2010; Niccolai, Dorst, Myers, & Kissinger,
2006). MSM were particularly unlikely to disclose to unknown status partners. This study is
unique in directly comparing disclosure among the three subgroups across sexual
partnership types. Our findings suggest future disclosure research should focus as much on
relationship characteristics as on gender and sexual orientation of PLWHA.
Most PLWHA reported experiencing HIV-related stigma, and individuals who experienced
more stigma were less likely to disclose their HIV status (Simbayi et al., 2007; Smith et al.,
2008). This study went beyond previous work in showing that the association between
stigma and disclosure did not differ between subgroups or across relationship types,
suggesting this association is extremely robust. Effective methods of reducing HIV-related
stigma and enhancing PLWHA’s efficacy to disclose in the face of stigma are urgently
needed (Chaudoir, Fisher, & Simoni, 2011).
Limitations
While we stressed participant confidentiality and used an ACASI to help minimize the recall
and social desirability biases to which self-reported data may be subject (Des Jarlais et al.,
1999), participants may have still over-reported disclosure. Second, because we did not
collect data from participants’ sexual partners, we were unable to conduct analyses at the
dyad level. Finally, our findings may not generalize to PLWHA who are not in care.
Conclusion
This study highlights both differences and similarities among MSM, heterosexual men, and
women living with HIV. As the HIV prevention toolkit expands with the success of recent
PrEP and “treatment as prevention” studies (Brooks et al., 2011; Cohen et al., 2011), HIV
serostatus disclosure is increasingly important and beneficial for serodiscordant partners.
While future studies could explore further the meaning and process of disclosure, our
findings suggests that interventions to improve effective disclosure may need to be tailored
on sexual partnership characteristics, particularly for MSM.
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Percentage of HIV Serostatus Disclosure among PLWHA in the Full Sample and by
Subgroup.
Note: MSM = men who have sex with men. Full Disclosure = disclosed HIV serostatus to
all sexual partners. Non-Disclosure = did not fully disclose HIV serostatus to all partners.
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Percentage of HIV Serostatus Disclosure among PLWHA based on Sexual Partner
Relationship Types.
Note: Mixed Partner Types: combination of primary and casual partners. Full Disclosure =
disclosed HIV serostatus to all sexual partners. Non-Disclosure = did not fully disclose HIV
serostatus to all partners.
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Percentage of HIV Serostatus Disclosure among PLWHA based on Serostatus of their
Sexual Partners.
Note: Mixed serostatus = any combination of HIV+, HIV−, and unknown serostatus
partners. Full Disclosure = disclosed HIV serostatus to all sexual partners. Non-Disclosure =
did not fully disclose HIV serostatus to all partners.
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Age [M (SD)] 42.2 (9.0) 40.0 (9.5) 44.9 (7.9) 42.8 (8.5)
Race
 African-American 238 (70.0) 78 (56.9) 70 (80.5) 90 (77.6)
 White 72 (21.2) 47 (34.3) 9 (10.3) 16 (13.8)
 Other 30 (8.8) 12 (8.8) 8 (9.2) 10 (8.6)
Education
 High School or Less 187 (55.0) 41 (29.7) 69 (79.3) 77 (67.0)
 Some College or More 153 (45.0) 97 (70.3) 18 (20.7) 38 (33.0)
Employment
 Not Employed 212 (62.2) 75 (54.4) 60 (69.0) 77 (66.4)
 Full or Part-Time 129 (37.8) 63 (45.6) 27 (31.0) 39 (33.6)
Annual income
 $10,000 or less 169 (51.7) 58 (42.7) 51 (63.8) 60 (54.1)
 $10,001 to $20,000 83 (25.4) 39 (28.7) 19 (23.8) 25 (22.5)
 >$20,001 75 (22.9) 39 (28.7) 10 (12.5) 26 (23.4)
Clinical Characteristics
Detectable Viral Load 128 (37.7) 57 (41.3) 28 (32.6) 43 (37.1)
Yrs since Diagnosis [M (SD)] 9.7 (6.0) 9.3 (6.5) 10.8 (5.8) 9.1 (5.5)
Note: All participants came from SafeTalk, a safer sex intervention among adults in the southeastern U.S. (Golin et al., 2012). MSM= men who
have sex with men. When men indicated they had had sexual contact with both men and women in the previous three months, they were
categorized as MSM (n=5).
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 Primary partners only 214 (62.9) 59 (42.8) a 58 (67.4) b 97 (83.6) c
 Casual partners only 84 (24.7) 52 (37.7) a 21 (24.4) a 11 (9.5) b
 Mixed relationship type partners 42 (12.3) 27 (19.5) a 7 (8.1) 8 (6.9) b
Partner Serostatus
 HIV+ partners only 108 (32.3) 43 (31.1) 30 (34.5) 35 (30.7)
 HIV− partners only 141 (42.3) 37 (26.8) a 39 (44.8) b 65 (56.0) b
 Unknown serostatus partners only 56 (16.7) 30 (21.7) 10 (11.5) 16 (13.8)
 Mixed serostatus partners 36 (10.6) 28 (20.3) a 8 (9.2) b 0 (0) c
Note: All participants came from SafeTalk, a safer sex intervention among adults in thesoutheastern U.S. (Golin et al., 2012). Mixed relationship
type partners = both primary and casual partners. Mixed status partners = any combination of HIV+, HIV−, and unknown status partners.
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Table 3























 Primary partners only 50/59 84.8 55/58 94.8 92/97 94.8 χ(2) = 5.95+
 Casual partners only 26/52 50.0 14/21 66.7 5/11 45.5 χ(2) = 2.01
 Mixed relationship type 19/27 70.4 5/7 71.4 2/8 25.0 χ(2) = 5.71+
Partner Serostatus
 HIV+ partners only 40/43 93.0 30/30 100 34/35 97.1 χ(2) = 2.52
 HIV− partners only 33/37 89.2 34/39 87.2 54/65 83.1 χ(2) = 0.81
 Unknown serostatus only 7/30 23.3 a 5/10 50.0 11/16 68.8 b χ(2) = 9.29*
 Mixed serostatus 15/28 53.6 6/8 75.0 0/0 0 χ(2) = 1.18
Note: All participants came from SafeTalk, a safer sex intervention among adults in the southeastern U.S. (Golin et al., 2012) #Disclose = Number
of people who disclosed to all partners. #In Group = number of people in part cular group. Disclosure = full HIV serostatus disclosure. Mixed
relationship type = both primary and casual partners. Mixed serostatus = any combination of HIV+, HIV−, and unknown serostatus partners.
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